Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | SHFS 0.1324 -61.39% | XXII 0.1977 -8.34% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | RBNE 0.19 -2.56% | YFOR 0.2236 -1.58% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | TQQQ 66.29 -0.20% | TSLL 9.76 -1.21% | VZ 44.66 -1.19% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | GRAB 2.79 -2.11% | AIOK 12.02 182.82% | SQQQ 39.68 0.20% | ONDS 6.2 2.99% | LABT 0.31 -36.67% | AAPL 347.725 -0.14% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | IREN 24.905 -2.37% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | NFLX 65.85 -1.79% | QID 14.55 0.14% | CLRO 3.25 69.27% | WULF 11.32 0.00%
CNConnect Biopharma Holdings Limited logo

Connect Biopharma Holdings Limited (CNTB)

NASDAQ Global Market · Currency in USD
$0.77 ▲ +0.00 (+0.58%)
At close: Oct 23, 4:00 PM ET. Market closed.
$0.77 ▲ +0.00 (+0.46%)
After hours: Oct 23, 7:30 PM ET

Summary

Previous Close
$0.76
Open
$0.76
Day's Range
$0.74 – $0.78
52 Week Range
$0.73 – $3.82
Volume
344,584
Avg. Volume
2,964,284
Market Cap
$48.27M
Beta (5Y Monthly)
-0.22
PE Ratio (TTM)
--
EPS (TTM)
-$0.82
Earnings Date
Nov 11, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$6.60

Profile: Connect Biopharma Holdings Limited

Sector
Healthcare
Industry
Biotechnology
Full-time employees
64
CEO
Barry D. Quart

Connect Biopharma Holdings Limited is a clinical-stage biopharmaceutical company dedicated to discovering and advancing immune modulators. Its primary objective is to develop treatments for serious autoimmune diseases and various inflammatory conditions. The company's lead investigational therapy is CBP-201, an anti-interleukin-4 receptor alpha antibody.

Earnings

Next report: Wed, Nov 11, 2026
EPS estimate -$0.27 · Revenue est. $114.86K
DateEst.Actual
Aug 12, 2026-$0.31-$0.27Beat
May 12, 2026-$0.29-$0.34Miss
Mar 31, 2026-$0.30-$0.27Beat
Nov 12, 2025-$0.03-$0.04Miss
Aug 13, 2025-$0.22-$0.03Beat
May 15, 2025-$0.26-$0.03Beat

Analyst view

Consensus price target
$6.60 ▲ +761.1%
Range $4.00 – $8.00
Rating: Buy
Buy 100% · Hold 0% · Sell 0%

Get free alerts on CNTB and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.